Menopause News and Research

RSS

Menopause is the time in a woman's life when her period stops. It usually occurs naturally, most often after age 45. Menopause happens because the woman's ovary stops producing the hormones estrogen and progesterone.

Experts recommend vitamin D supplementation for menopausal women

A group of experts has prepared a report on vitamin D supplementation for menopausal women after it was revealed that Europeans have suffered an alarming decrease in their levels of this vitamin. In their opinion, the ideal would be to maintain blood levels above 30 ng/ml. Vitamin D is essential to the immune system and processes such as calcium absorption.

11 Jan 2012

Experts share 10 symptoms of cervical and other gynecologic cancers

Pelvic pain and abnormal bleeding aren't the only signs of gynecologic cancer. As part of Cervical Health Awareness Month in January, experts at The University of Texas MD Anderson Cancer Center share other symptoms that often are overlooked.

6 Jan 2012

Cancer death rates declining - still room for improvement: Report

According to a new report from the American Cancer Society, fewer Americans are dying of cancer. The society's annual report on cancer statistics showed that cancer death rates have fallen nearly two percent for both men and women over the past five years. However experts warn that people still need to cut down their cancer risk.

5 Jan 2012

Daily doses of S-equol reduce hot flashes in postmenopausal women

Daily doses of a soy germ-based nutritional supplement containing S-equol significantly improved menopausal symptoms, including significantly reducing hot flash frequency after 12 weeks according to a placebo-controlled study in postmenopausal Japanese women published in the peer-reviewed Journal of Women's Health.

5 Jan 2012

Bionovo enters $5M securities purchase agreement with Socius

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that it has entered into a $5 million securities purchase agreement with Socius CG II, Ltd. ("Socius"), a Bermuda-based subsidiary of Socius Capital Group, LLC.

4 Jan 2012

Top-line results from Noven's LDMP Phase 3 clinical study on menopausal VMS

Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced top-line results from the first of two planned Phase 3 clinical studies evaluating low-dose mesylate salt of paroxetine (LDMP, formerly referred to as Mesafem) for the treatment of vasomotor symptoms (VMS) associated with menopause.

23 Dec 2011

Consistent evidence that HRT use associated with breast cancer

McMaster University researchers have found consistent evidence that use of hormone replacement therapy (HRT) is associated with breast cancer globally.

22 Dec 2011

DHEA hormone may help a woman's menopausal symptoms, sex life

A new study has shown that the DHEA, a hormone mostly secreted by the adrenal glands, may be able to help a woman's menopausal symptoms, as well as giving her a better sex life.

20 Dec 2011

Side effects and non-compliance with breast cancer therapy

Yet another study showed that more than a third of women taking a certain class of breast cancer drugs are so bothered by side effects that they stop taking the pills before their treatment is complete

12 Dec 2011

Bone drug effective in improving breast cancer survival

In a chance finding a bone drug was found to be effective in breast cancer. While doctors were prescribing young women a medicine to keep their bones strong during breast cancer treatment they noted that after seven years it did more than that - the bone drug improved survival, as much as most chemotherapy could do.

12 Dec 2011

The contraceptive pill could reduce risk of ovarian and uterine cancer in nuns

Professor Roger Short, from the University of Melbourne, and Dr Kara Britt, from Monash University, argue in a comment piece in The Lancet, that since the contraceptive pill reduces overall mortality and mortality specifically linked to ovarian and uterine cancer, nuns should be given the pill for health, rather than contraceptive, reasons.

9 Dec 2011

Ovary removal in younger women may lead to low-bone mineral density, arthritis

Having both ovaries removed before age 45 is strongly associated with low-bone mineral density and arthritis in later years, according to a new study by Johns Hopkins oncologists and epidemiologists. The analysis covered several thousand women who took part in a U.S. government-sponsored, multiyear national health study, and excluded women whose ovaries were removed due to cancer.

9 Dec 2011

Breast cancer risks and management updates

A new report that looks at the environmental factors that affect risk of breast cancer is out. It suggests that women can reduce their risk by avoiding unnecessary medical radiation, forgoing hormone treatments for menopause that combine estrogen and progestin, limiting alcohol intake and minimizing weight gain.

8 Dec 2011

State roundup: Aetna suing over Mich. BCBS hospital deals; ACLU threatens Ohio abortion suit

The latest challenge was a lawsuit filed Tuesday in Detroit's federal court by insurance giant Aetna, one of the nation's largest health plans, with 35 million members. The suit alleges a violation of federal antitrust laws, claiming the Blues raised rates for Michigan consumers over the last four years and used the money to reward hospitals with higher payments if they charged Blues' competitors the same or higher rates.

8 Dec 2011

AmLactin can help the skin through menopause

Womanhood definitely has its advantages—studies even show we live longer than men—but menopause isn't on the list of perks. Sometime between the ages of 40-58, our bodies will inevitably experience a drop in estrogen production and begin a metamorphosis.

7 Dec 2011

BUSM professor receives 2011 ACN Communication Media Award

Michael F. Holick, PhD, MD, director of the General Clinical Research Unit and professor of medicine, physiology and biophysics at Boston University School of Medicine (BUSM) was selected by the American College of Nutrition (ACN) Awards Committee as the 2011 recipient of the ACN Communication Media Award.

23 Nov 2011

Coffee may protect against womb cancer: Study

For the study the researchers looked at coffee consumption and endometrial cancer risk in more than 67,000 women aged between 34 and 59 enrolled in the long-running Nurses' Health Study. The researchers found that women who took more than four cups of coffee a day over a 26-year period were 25 percent less likely to get the cancer.

22 Nov 2011

BioSante listed on NASDAQ Biotechnology Index

BioSante Pharmaceuticals, Inc. today announced that it has been added to the NASDAQ Biotechnology Index, effective prior to the stock market open today, November 21, 2011.

21 Nov 2011

Bionovo initiates Menerba Phase 3 trial in menopausal hot flashes

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that the first patient has now been randomized and will begin dosing in the Phase 3 pivotal clinical trial evaluating the safety and efficacy of two doses of Menerba (MF101) among a cohort of postmenopausal women for the treatment of menopausal hot flashes.

17 Nov 2011

Additional results from BioSante's LibiGel pK study on HSDD

BioSante Pharmaceuticals, Inc., today announced additional results from its principal LibiGel (testosterone gel) pharmacokinetic (pK) study. Top line data from this study were announced on September 12, 2011.

16 Nov 2011